No Data
No Data
TD Cowen Maintains Kezar Life Sciences(KZR.US) With Buy Rating
TD Cowen Remains a Buy on Kezar Life Sciences (KZR)
Maintaining Hold on Kezar Life Sciences Amid Safety Concerns and Financial Valuation
Express News | Kezar Life Sciences Inc : Jefferies Cuts Target Price to $3 From $13
JonesTrading Maintains Kezar Life Sciences(KZR.US) With Hold Rating
Kezar Life Sciences Halts Trial of Lupus-Nephritis Treatment After Deaths